Live news related to SANOFI stock (FR0000120578): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
HSBC ajuste sa position sur Sanofi ce mercredi 4 février 2026.
Sanofi announces that venglustat has met all primary endpoints in the LEAP2MONO phase 3 study for type 3 Gaucher's disease. The company will proceed w…
Sanofi's stock shows an increase of 1.36% to 80.28 euros this Monday, February 2, 2026, at mid-session, driven by the announcement of a major clinical…
Sanofi shares increased by 1.66% this Friday, January 30, 2026, in the late afternoon, reaching 78.36 euros. This rebound follows the publication of s…
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended conditional marketing authorization for San…
Sanofi has reported strong results for the fourth quarter and the fiscal year 2025, confirming an acceleration in revenue growth and a significant inc…
Sanofi shares closed at 77.54 euros this Wednesday, January 28, 2026, down 2.77% from the previous session. The pharmaceutical stock is now down 23.49…
Citigroupe établit une recommandation neutre sur Sanofi ce mardi 27 janvier 2026.
The French pharmaceutical company announced on Thursday positive results from two global phase 3 studies on amlitelimab, a monoclonal antibody targeti…
Sanofi announces positive results from two Phase 3 studies of amlitelimab in atopic dermatitis, with regulatory submissions planned for the second hal…
